A citation-based method for searching scientific literature

Chandak Upagupta, Chiko Shimbori, Rahmah Alsilmi, Martin Kolb. Eur Respir Rev 2018
Times Cited: 81







List of co-cited articles
638 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
575
23

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
594
17

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
16

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
14

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
390
14

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation.
Adam J Booth, Ryan Hadley, Ashley M Cornett, Alyssa A Dreffs, Stephanie A Matthes, Jessica L Tsui, Kevin Weiss, Jeffrey C Horowitz, Vincent F Fiore, Thomas H Barker,[...]. Am J Respir Crit Care Med 2012
359
13

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
12

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
393
9

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
930
9

The impact of TGF-β on lung fibrosis: from targeting to biomarkers.
Isis E Fernandez, Oliver Eickelberg. Proc Am Thorac Soc 2012
378
9

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
169
9

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
9

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
9

The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease.
Gerald Burgstaller, Bettina Oehrle, Michael Gerckens, Eric S White, Herbert B Schiller, Oliver Eickelberg. Eur Respir J 2017
175
8

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Yongyu Wang, Phillip J Kuan, Chao Xing, Jennifer T Cronkhite, Fernando Torres, Randall L Rosenblatt, J Michael DiMaio, Lisa N Kinch, Nick V Grishin, Christine Kim Garcia. Am J Hum Genet 2009
303
8

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Paul A Reyfman, James M Walter, Nikita Joshi, Kishore R Anekalla, Alexandra C McQuattie-Pimentel, Stephen Chiu, Ramiro Fernandez, Mahzad Akbarpour, Ching-I Chen, Ziyou Ren,[...]. Am J Respir Crit Care Med 2019
424
8

Cellular senescence mediates fibrotic pulmonary disease.
Marissa J Schafer, Thomas A White, Koji Iijima, Andrew J Haak, Giovanni Ligresti, Elizabeth J Atkinson, Ann L Oberg, Jodie Birch, Hanna Salmonowicz, Yi Zhu,[...]. Nat Commun 2017
593
8

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
412
8

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
114
8

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
435
8

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
Richard J Allen, Joanne Porte, Rebecca Braybrooke, Carlos Flores, Tasha E Fingerlin, Justin M Oldham, Beatriz Guillen-Guio, Shwu-Fan Ma, Tsukasa Okamoto, Alison E John,[...]. Lancet Respir Med 2017
128
7

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
7

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
659
7

Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.
Yong Zhou, Xiangwei Huang, Louise Hecker, Deepali Kurundkar, Ashish Kurundkar, Hui Liu, Tong-Huan Jin, Leena Desai, Karen Bernard, Victor J Thannickal. J Clin Invest 2013
283
7

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts. Lancet Respir Med 2018
114
7

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, A Whitney Brown, Jeffrey A Golden, Lawrence A Ho, Marlies S Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E Antin-Ozerkis,[...]. JAMA 2018
98
7

Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.
Gerald S Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey E Lukashev, Paul H Weinreb, Kenneth J Simon, Kyungmin Hahm, Normand E Allaire, Nicola J Rinaldi,[...]. Am J Respir Crit Care Med 2008
290
7


Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.
Nikos Oikonomou, Marios-Angelos Mouratis, Argyris Tzouvelekis, Eleanna Kaffe, Christos Valavanis, George Vilaras, Andreas Karameris, Glenn D Prestwich, Demosthenes Bouros, Vassilis Aidinis. Am J Respir Cell Mol Biol 2012
152
7

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
7

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.
Ganesh Raghu, Kevin K Brown, Harold R Collard, Vincent Cottin, Kevin F Gibson, Robert J Kaner, David J Lederer, Fernando J Martinez, Paul W Noble, Jin Woo Song,[...]. Lancet Respir Med 2017
134
7

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Fei Liu, David Lagares, Kyoung Moo Choi, Lauren Stopfer, Aleksandar Marinković, Vladimir Vrbanac, Clemens K Probst, Samantha E Hiemer, Thomas H Sisson, Jeffrey C Horowitz,[...]. Am J Physiol Lung Cell Mol Physiol 2015
382
7

Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis.
Aaron R Froese, Chiko Shimbori, Pierre-Simon Bellaye, Mark Inman, Steffen Obex, Safoora Fatima, Gisli Jenkins, Jack Gauldie, Kjetil Ask, Martin Kolb. Am J Respir Crit Care Med 2016
115
6


Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
324
6


Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.
Fei Liu, Justin D Mih, Barry S Shea, Alvin T Kho, Asma S Sharif, Andrew M Tager, Daniel J Tschumperlin. J Cell Biol 2010
458
6

Telomerase mutations in families with idiopathic pulmonary fibrosis.
Mary Y Armanios, Julian J-L Chen, Joy D Cogan, Jonathan K Alder, Roxann G Ingersoll, Cheryl Markin, William E Lawson, Mingyi Xie, Irma Vulto, John A Phillips,[...]. N Engl J Med 2007
837
6

Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.
Aleksandar Marinković, Fei Liu, Daniel J Tschumperlin. Am J Respir Cell Mol Biol 2013
95
6

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
932
6

The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis.
Friedrich Grimminger, Andreas Günther, Carlo Vancheri. Eur Respir J 2015
89
6

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Christopher J Ryerson, Vincent Cottin, Kevin K Brown, Harold R Collard. Eur Respir J 2015
97
6

Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.
Bethany B Moore, Thomas A Moore. Ann Am Thorac Soc 2015
70
7

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
380
6


Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history.
Giacomo Sgalla, Alice Biffi, Luca Richeldi. Respirology 2016
81
6

Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Francesco Salton, Maria Concetta Volpe, Marco Confalonieri. Medicina (Kaunas) 2019
64
7

Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Christopher J Philp, Ivonne Siebeke, Debbie Clements, Suzanne Miller, Anthony Habgood, Alison E John, Vidya Navaratnam, Richard B Hubbard, Gisli Jenkins, Simon R Johnson. Am J Respir Cell Mol Biol 2018
55
9

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.
Pierre-Jean Wipff, Daniel B Rifkin, Jean-Jacques Meister, Boris Hinz. J Cell Biol 2007
870
6

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Taylor S Adams, Jonas C Schupp, Sergio Poli, Ehab A Ayaub, Nir Neumark, Farida Ahangari, Sarah G Chu, Benjamin A Raby, Giuseppe DeIuliis, Michael Januszyk,[...]. Sci Adv 2020
195
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.